Citation: "86 FR 24867"

Document Number: "Docket Nos. FDA-2020-N-2030; FDA-2017-N-4951; FDA-2017-N-5569; FDA-2020-N-1652; FDA-2017-N-7012; and FDA-2019-N-4763"

Page Number: "24867"

"Notices"

Agency: "Food and Drug Administration, HHS."

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA).

   FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.

   SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the PRA (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

Table 1-List of Information Collections Approved by OMB                                                                        

Title of collection                        OMB control No.                          Date approval expires                       
Applications for FDA Approval to Market a New Drug        0910-0001                             3/31/2024                             
Medical Devices; Humanitarian Use Devices             0910-0332                             3/31/2024                             
Medical Devices; Device Tracking                 0910-0442                             3/31/2024                             
Dispute Resolution Procedures for Science Based Decision on    0910-0566                             3/31/2024                             
Products Regulated by CVM                                                                                       
Use of Public Human Genetic Variant Databases to Support Clinical 0910-0850                             3/31/2024                             
Validity for Genetic and Genomic-Based In Vitro Diagnostics                                                                      
Assessment of Terms and Phrases Commonly Used in Prescription   0910-0895                             3/31/2024                             
Drug Promotion                                                                                            

   Dated: May 4, 2021.

Lauren K. Roth,

Acting Principal Associate Commissioner for Policy.

[FR Doc. 2021-09811 Filed 5-7-21; 8:45 am]

BILLING CODE 4164-01-P